BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 30, 2019
View Archived Issues
Basophils protect against sepsis
Read More
Kinase plays role in radiation resistance
Read More
Antihypertensive drug enhances ovarian cancer chemotherapy
Read More
FDA clears IND for ALLO-501 program
Read More
Primary endpoint met in pivotal phase III dengue vaccine TIDES study
Read More
MMV and DNDi launch a new project to accelerate the discovery of new drugs for pandemic diseases
Read More
Discovery of multireceptor ligands as novel class of atypical antipsychotic drugs for schizophrenia
Read More
GlaxoSmithKline presents new CREB-2 inhibitors
Read More
U.S. Department of Health & Human Services patents fatty acid derivatives
Read More
New PD-1/PD-L1 interaction inhibitors described by Rijksuniversiteit Groningen
Read More
New beta-lactamase inhibitors discovered at Sumitomo Dainippon Pharma
Read More
Targeting NP1/MICAL3/CRMP2/Numb axis in breast cancer
Read More
Researchers develop B. pseudomallei-induced melioidosis mouse model to characterize T-cell responses
Read More
Shanghai Institute of Materia Medica discloses PARP-1/2 inhibitors
Read More
CAP-1002 demonstrates safety and efficacy in phase I/II HOPE-Duchenne study
Read More
Coagulation factor XI inhibitors identified at Sichuan Kelun-Biotech Biopharmaceutical
Read More
Phase IIb study of SB-623 for motor deficits associated with chronic ischemic stroke misses endpoint
Read More
Orphazyme releases full data from phase II/III study of arimoclomol in Niemann-Pick disease type C
Read More
Allakos reports phase II data on AK-002 in cholinergic urticaria and symptomatic dermographism
Read More
CPSF1 mutations tied to early-onset high myopia
Read More
IMPACT Therapeutics identifies wee1-like protein kinase inhibitors
Read More
Phase III study of oral contraceptive Estelle meets primary efficacy endpoint
Read More
Genentech to discontinue phase III CREAD 1 & 2 studies of crenezumab in early sporadic Alzheimer's
Read More